Synergy CHC Corp.SNYR
Price (close)
$0.02
Market cap
—
P/E
—
Revenue (TTM)
$27.7M
Net income
-$15.8M
Dividend yield
—
1-year total return
—
Net margin
-57.0%
Revenue growth
-17.5%
Debt / equity
—
What Synergy CHC Corp. does.
health care, beauty, and lifestyle products. Our current brand portfolio consists of two marquee brands, FOCUSfactor, a clinically-tested brain
health supplement (this study was performed independently and is not related to any U.S. Food and Drug Administration (“FDA”)
-approved investigational new drug (IND) application) that has been shown to improve memory, concentration and focus, and Flat Tummy,
Revenue and profit, by fiscal year.
| Fiscal year | 2018 | 2019 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $33.8M | $29.4M | — | $42.8M | $34.8M | $30.4M |
| Net income | -$6.2M | -$9.2M | — | $6.3M | $2.1M | -$12.3M |
| Free cash flow | $1.2M | — | — | — | — | — |
More on SNYR.
- Synergy CHC Corp. summary
- Synergy CHC Corp. financial statements
- Synergy CHC Corp. key metrics
- Synergy CHC Corp. health scores and style box
- Synergy CHC Corp. earnings
- Synergy CHC Corp. dividends
- Synergy CHC Corp. valuation
- Synergy CHC Corp. ownership and insiders
- Synergy CHC Corp. peers
Figures from Synergy CHC Corp.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.